Doctor profile · Federal record
Dr. MOLLY BRADDOCK, PA-C
Physician Assistant · SWANSEA, IL
- NPI 1881134765
- Accepts Medicare
- 10 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4948 BENCHMARK CENTRE DR
SWANSEA, IL 622262027
(618) 628-2588
fax (618) 628-1363
Credentials & registration
- NPI registered
- February 2017 — 9 yrs on file
- Profile last updated
- January 3, 2020
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Illinois #085.006105
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881134765. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,797
Distinct HCPCS
10
Medicare allowed
$70,583
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 715 | 145 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 227 | 189 | $76 | |
17000 |
Destruction of precancer skin growth, 1 growth | 218 | 188 | $45 | |
17110 |
Destruction of skin growth, 1-14 growths | 133 | 119 | $92 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 90 | 84 | $47 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 89 | 15 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 87 | 84 | $77 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 76 | 66 | $106 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 45 | 45 | $61 | |
11103 |
Biopsy of related skin growth, each additional growth | 40 | 22 | $41 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 178. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$3,234
Transactions
163
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 34 | $626.95 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $330.10 | |
| E.R. Squibb & Sons, L.L.C. | 21 | $302.66 | |
| LEO Pharma Inc. | 12 | $291.48 | |
| Novartis Pharmaceuticals Corporation | 12 | $258.76 | |
| Dermavant Sciences, Inc. | 15 | $255.81 | |
| Janssen Biotech, Inc. | 9 | $172.11 | |
| Amgen Inc. | 9 | $170.07 | |
| UCB, Inc. | 11 | $167.81 | |
| Lilly USA, LLC | 8 | $146.35 | |
| Incyte Corporation | 5 | $142.73 | |
| PFIZER INC. | 6 | $116.45 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $57.82 | |
| GENZYME CORPORATION | 2 | $39.62 | |
| Verrica Pharmaceuticals Inc. | 2 | $35.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
246
Patients
145
Total drug cost
$83,275
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 44 | 35 | $2,390 |
| Triamcinolone Acetonide | Generic | 42 | 38 | $478 |
| Doxycycline Hyclate | Generic | 40 | 21 | $892 |
| Hydrocortisone | Generic | 30 | 23 | $191 |
| Ketoconazole | Generic | 22 | 17 | $562 |
| Spironolactone | Generic | 18 | 0 | $326 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 14 | 0 | $998 |
| Hydroxyzine Hcl | Generic | 13 | 0 | $61 |
| Taltz Autoinjector (Ixekizumab) | Brand | 12 | 0 | $77,296 |
| Mupirocin | Generic | 11 | 11 | $81 |